HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

J. Biol. Chem., Vol. 282, Issue 36, 26629-26640, September 7, 2007

This Article Full Text Full Text (PDF) Supplemental Data All Versions of this Article: 282/36/26629    most recent M701807200v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Klaile, E. Articles by Lucka, L. Search for Related Content PubMed PubMed Citation Articles by Klaile, E. Articles by Lucka, L. Social Bookmarking                      What's this?

The Cell Adhesion Receptor Carcinoembryonic Antigen-related Cell Adhesion Molecule 1 Regulates Nucleocytoplasmic Trafficking of DNA Polymerase -Interacting Protein 38^*

Esther Klaile¹, Mario M. Müller, Christoph Kannicht^¶, Wolfgang Otto, Bernhard B. Singer^||, Werner Reutter, Björn Öbrink², and Lothar Lucka²

From the Institut für Biochemie und Molekularbiologie, Charité, Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin-Dahlem D-14195, Germany, the ^¶Molecular Biochemistry Department, Octapharma Pre-Clinical Research and Development, Arnimallee 22, Berlin D-14195, Germany, the ^||Institute for Anatomy, University Hospital Essen, Hufelandstrasse 55, Essen D-45147, Germany, and the Department of Cell and Molecular Biology, Medical Nobel Institute, Karolinska Institutet, Stockholm SE-17177, Sweden

The homophilic cell-cell adhesion receptor CEACAM1 (carcinoembryonic antigen-related cell adhesion molecule 1, CD66a) acts as a regulator of contact-dependent cell survival, differentiation, and growth. It is involved in the control of proliferation in hematopoietic and epithelial cells and can act as a tumor suppressor. In this study, we identify DNA polymerase -interacting protein 38 (PDIP38) as a novel binding partner for CEACAM1-L and CEACAM1-S. We show that PDIP38 can occur in the nucleus, in the cytoplasm and at the plasma membrane in NBT-II, IEC18, RBE, and HeLa cells and that the distribution in NBT-II cells is influenced by the confluency of the cells. We also demonstrate that the interaction of CEACAM1 and PDIP38 is of functional importance in NBT-II cells, which co-express the long and the short CEACAM1 isoform. In subconfluent, proliferating NBT-II cells, perturbation of CEACAM1 by antibody clustering induces increased binding to PDIP38 and results in rapid recruitment of PDIP38 to the plasma membrane. The same treatment of confluent, quiescent NBT-II cells leads to a different response, i.e. translocation of PDIP38 to the nucleus. Together, our data show that PDIP38 can shuttle between the cytoplasmic and the nuclear compartments and that its subcellular localization is regulated by CEACAM1, implicating that PDIP38 may constitute a novel downstream target of CEACAM1 signaling.

Received for publication, March 1, 2007 , and in revised form, July 9, 2007.

^* This work was supported by the Deutsche Forschungsgemeinschaft (Grant SFB 366, TP C1), the Sonnenfeld-Stiftung, the Fonds der Chemischen Industrie, the Swedish Research Council (Project 32X-05200), the Swedish Cancer Foundation (Project 4720), the Marianne and Marcus Wallenbergs Stiftelse, and the Karolinska Institutet. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

The on-line version of this article (available at http://www.jbc.org) contains supplemental Figs. S1 and S2.

² Both authors contributed equally to this work.

¹ To whom correspondence should be addressed: Esther Klaile, Dept. of Cell and Molecular Biology, Medical Nobel Institute, Karolinska Institutet, von Eulers väg 3, SE-17177 Stockholm, Sweden. Tel.: +46-8-52487302; Fax: +46-8-301833; E-mail: esther.klaile{at}ki.se.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				L. Jin, Y. Li, C.-J. Chen, M. A. Sherman, K. Le, and J. E. Shively Direct Interaction of Tumor Suppressor CEACAM1 with Beta Catenin: Identification of Key Residues in the Long Cytoplasmic Domain Experimental Biology and Medicine, July 1, 2008; 233(7): 849 - 859. [Abstract] [Full Text] [PDF]